Breastfeeding duration associated with improved educational outcomes in later life

Children who are breastfed for longer appear to be more likely to gain slightly better results in their school GSCEs at age 16 compared with non-breastfed children, suggests a study published online in the journal Archives of Disease in Childhood. The evidence of improved educational outcomes is still apparent even when various factors are taken into account such as people's […]

» Read more

Tips to checking your skin for skin cancer

Skin cancer can pop up anywhere on your skin, including the soles of your feet and even under your fingernails. That’s what happened to Isabel Lievano, who was diagnosed with melanoma when her dermatologist determined that a persistent black spot under her fingernail was the deadliest form of skin cancer. Lievano, 69, lost her nail, but not her finger or […]

» Read more

Transcription factor prevents bone frailty in chronic kidney disease

Northwestern Medicine investigators have discovered that the overexpression of a transcription factor prevented bone loss in mouse models of chronic kidney disease, according to a recent study published in the Journal of Clinical Investigation. The findings demonstrate that the transcription factor hepatocyte nuclear factor 4 alpha (HNF4α) regulates bone frailty and is implicated in the development of renal osteodystrophy (ROD), […]

» Read more

Researchers discover numerous undescribed metabolic processes

Researchers at the Faculty of Medicine at the University of Freiburg have gained significant new insights into metabolic processes in the kidney. The scientists from the Institute of Genetic Epidemiology at the Medical Center—University of Freiburg measured tiny molecules, so-called metabolites, which occur in blood and urine and reflect our metabolism, in samples from more than 5,000 study participants. They […]

» Read more

Groundbreaking New Regimen for Advanced Hodgkin Lymphoma

Across patients’ age groups, adding the immune checkpoint inhibitor nivolumab to chemotherapy significantly improves progression-free survival in advanced stage Hodgkin lymphoma while also reducing toxicities, making it a new standard of care, compared with the CD30-targeting drug brentuximab vedotin. “[SWOG] S1826, the largest Hodgkin lymphoma study in National Clinical Trials Network history, is a key step toward harmonizing the pediatric […]

» Read more

Treatment found to reduce progression of rare blood cancer by 74%

A treatment that involves genetically modifying the body’s own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type of blood cancer, results showed Monday. Ciltacabtagene autoleucel—also known by its trade name Carvykti—was tested in a clinical trial involving 419 patients with multiple myeloma, whose disease was not responsive […]

» Read more

RA and Demyelinating Disease: No Consistent Link to TNFi

MILAN — Treatment of rheumatoid arthritis (RA) with tumor necrosis factor inhibitors (TNFi) does not appear to demonstrate a consistent and significant risk for demyelinating disease, according to a systematic literature review presented at the European Alliance of Associations for Rheumatology (EULAR) 2023 Annual Meeting. Dr Isabel Castrejon The review was conducted by Isabel Castrejon, MD, of the rheumatology department […]

» Read more
1 126 127 128 129 130 1,330